Submit A Case CPMS
Home - Network - Working Groups - Rare Disease Working Groups - Vascular Anomalies (VASCA-WG) - Clinical Decision Support Tools - Clinical Expert Consensus Statements
Vascular Anomalies (VASCA-WG)
Introduction Diseases covered
Experts & Centers
Experts Centers
Clinical Decision Support Tools
Clinical Expert Consensus Statements Clinical Outcome Measures Clinical Practice Guidelines (CPGs) adopted Do’s and Don’ts Gene-disease associations and genetic testing recommendations Patient Pathways
Registry
Research
Clinical Trials/Observational Studies Research Publications
Training and Education
E-Learning Pills of Knowledge (PoK) Webinars
VASCA Magazine

Clinical Expert Consensus Statements

The Vascular Anomalies Working Group (VASCA-WG) have developed consensus statements drawing from the latest research and clinical data to provide evidence-based recommendations for the diagnosis, treatment and management of these diseases.

The VASCA-WG is currently working on creating other expert consensus statement documents on various rare vascular anomalies.

Results (5)
VASCERN-VASCA Consensus Statement: Sirolimus and Fertility
December 20 2023

This document is based on the statement elaborated by ASPHO SIG (The American Society of Pediatric Hematology/Oncology Special Interest Group) and CaNVAS (Consortium of iNvestigators of Vascular AnomalieS), USA in December 2023, and further revised by the VASCERN (European Reference Network for Multisystemic Rare Vascular Diseases) VASCA (Vascular Anomalies) working group.

VASCERN Suonipoikkeavuuksien (VASCA) työryhmä – Tietoa koronaviruksesta (COVID-19) potilaille, joilla on vaikea suonipoikkeavuus
March 29 2023
Information COVID-19 pour les patients porteurs d’ Anomalies Vasculaires et/ou Lymphatiques
March 29 2023
VASCERN Vascular Anomalies (VASCA) Working Group – Statement concerning SARS-CoV-2 Vaccination for Patients with Vascular Malformations
January 15 2021
VASCERN Vascular Anomalies (VASCA) Working Group COVID-19 Statement (March 20, 2020)
March 20 2020

Initiated by the patient advocacy groups in Europe and the United States and their medical advisory teams and approved by the VASCA WG.

Skip to content